Refresh Optive Unit Dose
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Refresh Optive Unit Dose, covering 2026-03-13 to 2026-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease [Phase 3]